Eris Lifesciences Q3FY22 revenues at Rs 3,322 million, up seven per cent YoY
The company's EBITDA stood at Rs 1,217 million, up 13.5 per cent YoY and PAT stood at Rs 1,008 million, up 11.8 per cent YoY
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
Lonza’s full-year core EBITDA up 20.7 per cent on vaccine demand
Full-year core earnings before interest, tax, depreciation and amortisation (EBITDA) rose to 1.67 billion Swiss francs ($1.82…
Torrent Pharma December quarter profit slips 16 per cent to Rs 249 crores
The drugmaker had posted a net profit of Rs 297 crores in the October-December period of the 2020-21 fiscal
Biocon’s consolidated Q3FY22 revenue grows by 18 per cent YoY to Rs 2,223 crores
Biosimilars up by 28 per cent at Rs 981 crores; research services up by 10 per cent at Rs 641 crores and generics up by seven per…
Torrent Pharma recalls 27,000 bottles of BP lowering medicine in the US
According to the US health regulator, the company is recalling the affected lot due to it being "Superpotent;…
Pharma industry reports 53 deals worth $9.6 billion in November 2021: GlobalData
The industry reported 105 venture capital (VC) deals worth $4.2 billion in November 2021, compared to the last 12-month average…
Flipkart to enter healthcare sector via Flipkart Health+
Signs definitive agreements to acquire majority stake in SastaSundar.com, an online pharmacy and digital healthcare platform
India has robust manufacturing capability with sufficient skilled manpower to foster innovation
Poornachandra Tejasvi K, Senior Director - Emerging Markets, India, Pharma Intelligence, talks about shifts and trends in…
Lincoln Pharmaceuticals reports 13.27 per cent rise in standalone net profit at Rs 22.88 crores in…
Net revenues in Q2 FY22 at Rs 129.41 crores, up 4.78 per cent from Rs 123.51 crores in Q2 FY21
AstraZeneca Pharma India net profit declines 55 per cent to Rs 12 crores in Q2
The company had posted a net profit of Rs 26.33 crores for the corresponding period of the previous financial year, it said in a…
Masco Group acquires Keyplants AB, a provider of modular life science facilities
The move will strengthen Masco’s leadership in engineering technologies for life sciences
Amneal Pharma acquires injectable firm Punishka Healthcare for Rs 700 crores
The acquisition significantly enhances Amneal’s injectables manufacturing infrastructure, capabilities, and capacity to support…
Pharma sector study will identify steps to boost competition and ensure drug affordability: CCI…
Gupta said CCI is close to completing its study on the country’s pharmaceutical sector that is likely to be concluded within a…
Industry reports 48 deals worth $3 billion in Oct 2021: GlobalData
The healthcare industry reported 91 venture capital (VC) deals worth $2.7 billion in October 2021, compared to the last 12-month…
Lupin launches authorised generic version of Antara in US
Fenofibrate Capsules are indicated as adjunctive therapy to diet to reduce elevated low-density lipoprotein cholesterol, total…
India sees sizeable improvement in finished dosage reputation and growth ahead of CPhI India 2021
CPhI & P-mec India delivers hybrid event as country improves across all key performance metrics in CPhI global survey
Gattefossé launches three new pharmaceutical excipients
To ensure their international launch and success, Labrafac MC60, Gelucire 59/14 and Emulfree Duo conform to all regulatory…
Ayush market size crosses $18 billion
The latest RIS report pegs Ayush sector growth at 17 per cent during 2014-20
Biocon Biologics and Viatris’s Semglee preferred on Express Scripts’ largest formulary in US
Express Scripts, a leading pharmacy benefit management organisation, will list Viatris-labelled biosimilar Insulin Glargine as a…
Pharma industry reports 105 deals worth $27 billion in September
The pharma industry reported 104 venture capital (VC) deals worth $3.5 billion in September 2021, compared to the last 12-month…